Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lillian Chiu"'
Autor:
Ann-Lii Cheng, Jih-Hsiang Lee, Naoyuki Tajima, Shun-ichi Sasaki, Tomoko Ishizuka, Yu-Hsin Yen, Toshihiro Oguma, Masahiro Sugihara, Chia-Chi Lin, LiYin Lillian Chiu, Chih-Hung Hsu, Tom Wei-Wu Chen, James Chih-Hsin Yang
Publikováno v:
Investigational New Drugs
Summary Background Pexidartinib, a novel, orally administered small-molecule tyrosine kinase inhibitor, has strong selectivity against colony-stimulating factor 1 receptor. This phase I, nonrandomized, open-label multiple-dose study evaluated pexidar
Autor:
Patrick J. Kennedy, Gwendolyn E. Daly, Carol L. Karmen, Lillian Chiu Kennedy, Maria F. Capparelli
Publikováno v:
Emergency General Surgery in Geriatrics ISBN: 9783030622145
The internist plays a vital role in managing the elderly patient undergoing emergency surgery. Internists are involved in each stage of care, not only as primary care physicians but also as hospitalists. As the primary care provider (PCP), the intern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c88c17da99026734758d02ddc3f50c8
https://doi.org/10.1007/978-3-030-62215-2_11
https://doi.org/10.1007/978-3-030-62215-2_11
Autor:
Yu-Hsin Yen, Shun-ichi Sasaki, Ann-Lii Cheng, Jih-Hsiang Lee, Chia-Chi Lin, Chih-Hsin Yang, Lillian Chiu, Chih-Hung Hsu, Ling Zhang, Wei-Wu Chen
Publikováno v:
Molecular Cancer Therapeutics. 17:A080-A080
Background: Pexidartinib is a novel, orally active, small-molecule kinase inhibitor that selectively targets the colony-stimulating factor-1 receptor (CSF1R), as well as the receptors c-kit and oncogenic Flt3. Based on these targets, pexidartinib may